Lu Y - Search Results

1

Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.

Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L, Hendrix CW. Lu Y, et al. Antimicrob Agents Chemother. 2012 May;56(5):2777-9. doi: 10.1128/AAC.06160-11. Epub 2012 Feb 13. Antimicrob Agents Chemother. 2012. PMID: 22330926 Free PMC article.

2

Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods.

Lu Y, Goti V, Chaturvedula A, Haberer JE, Fossler MJ, Sale ME, Bangsberg D, Baeten JM, Celum CL, Hendrix CW. Lu Y, et al. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5379-86. doi: 10.1128/AAC.00559-16. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27353269 Free PMC article. Clinical Trial.

3

CYP3A5 genotype impacts maraviroc concentrations in healthy volunteers.

Lu Y, Fuchs EJ, Hendrix CW, Bumpus NN. Lu Y, et al. Drug Metab Dispos. 2014 Nov;42(11):1796-802. doi: 10.1124/dmd.114.060194. Epub 2014 Aug 12. Drug Metab Dispos. 2014. PMID: 25117426 Free PMC article.

4

Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc.

Lu Y, Hendrix CW, Bumpus NN. Lu Y, et al. Drug Metab Dispos. 2012 Dec;40(12):2221-30. doi: 10.1124/dmd.112.048298. Epub 2012 Aug 24. Drug Metab Dispos. 2012. PMID: 22923690 Free PMC article.

5

Response to "clinical relevance of CYP3A5 genotype on maraviroc exposures".

Lu Y, Fuchs EJ, Hendrix CW, Bumpus NN. Lu Y, et al. Drug Metab Dispos. 2015 May;43(5):773. doi: 10.1124/dmd.115.064188. Drug Metab Dispos. 2015. PMID: 25838403 Free PMC article. No abstract available.

6

Effects of ritonavir-boosted lopinavir on the pharmacokinetics of quinine.

Nyunt MM, Lu Y, El-Gasim M, Parsons TL, Petty BG, Hendrix CW. Nyunt MM, et al. Among authors: lu y. Clin Pharmacol Ther. 2012 May;91(5):889-95. doi: 10.1038/clpt.2011.326. Clin Pharmacol Ther. 2012. PMID: 22472986 Clinical Trial.

7

Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.

Savic RM, Lu Y, Bliven-Sizemore E, Weiner M, Nuermberger E, Burman W, Dorman SE, Dooley KE. Savic RM, et al. Among authors: lu y. Antimicrob Agents Chemother. 2014 Jun;58(6):3035-42. doi: 10.1128/AAC.01918-13. Epub 2014 Mar 10. Antimicrob Agents Chemother. 2014. PMID: 24614383 Free PMC article. Clinical Trial.

8

Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.

Dooley KE, Bliven-Sizemore EE, Weiner M, Lu Y, Nuermberger EL, Hubbard WC, Fuchs EJ, Melia MT, Burman WJ, Dorman SE. Dooley KE, et al. Among authors: lu y. Clin Pharmacol Ther. 2012 May;91(5):881-8. doi: 10.1038/clpt.2011.323. Clin Pharmacol Ther. 2012. PMID: 22472995 Free PMC article. Clinical Trial.

9

Renal excretion of pseudo-cross-linked human, porcine and bovine hemoglobins.

Urbaitis B, Lu YS, Fronticelli C, Bucci E. Urbaitis B, et al. Among authors: lu ys. Biochim Biophys Acta. 1992 Dec 8;1156(1):50-6. doi: 10.1016/0304-4165(92)90094-b. Biochim Biophys Acta. 1992. PMID: 1472538

10

Renal and systemic-hemodynamic response to isovolemic exchange transfusion with hemoglobin cross-linked with bis (3,5-dibromosalicyl) fumarate or albumin.

Matheson-Urbaitis B, Lu YS, Fronticelli C, Bucci E. Matheson-Urbaitis B, et al. Among authors: lu ys. J Lab Clin Med. 1995 Sep;126(3):250-60. J Lab Clin Med. 1995. PMID: 7665973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,337 results

Search Page

Filters